Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
1.560
-0.040 (-2.50%)
At close: Aug 14, 2026, 4:00 PM EDT
1.550
-0.010 (-0.64%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Codexis Employees
Codexis had 146 employees as of December 31, 2025. The number of employees decreased by 42 or -22.34% compared to the previous year.
Employees
146
Change (1Y)
-42
Growth (1Y)
-22.34%
Revenue / Employee
$532,048
Profits / Employee
-$210,432
Market Cap
170.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 146 | -42 | -22.34% | 146 | 0 |
| Dec 31, 2024 | 188 | 14 | 8.05% | 188 | 0 |
| Dec 31, 2023 | 174 | -74 | -29.84% | 174 | 0 |
| Dec 31, 2022 | 248 | -13 | -4.98% | 248 | 0 |
| Dec 31, 2021 | 261 | 80 | 44.20% | 261 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Coherus Oncology | 144 |
| MediWound | 121 |
| Nkarta | 108 |
| Tenaya Therapeutics | 70 |
| Armata Pharmaceuticals | 61 |
| Acumen Pharmaceuticals | 61 |
| Outlook Therapeutics | 17 |
| NervGen Pharma | 10 |
CDXS News
- 3 days ago - Codexis Earnings Call Transcript: Q2 2026 - Transcripts
- 3 days ago - Codexis Quarterly report: Q2 2026 - Filings
- 3 days ago - Codexis Earnings release: Q2 2026 - Filings
- 3 days ago - Codexis Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 11 days ago - Codexis Appoints David Butler, PhD, to Strategic Advisory Board - GlobeNewsWire
- 17 days ago - Codexis to Report Second Quarter 2026 Financial Results on August 11 - GlobeNewsWire
- 21 days ago - Codexis 16.667M share Spot Secondary priced at $1.50 - TheFly
- 22 days ago - Codexis Announces Pricing of Public Offering of Common Stock - GlobeNewsWire